Background illustration for clinical trials search

Paid Clinical Trials Wilmington

Discover 154 paid clinical trials in Wilmington, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostatic Neoplasms
Location: Myrtle Beach SC, Charleston SC, Charlotte NC,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07164443

Phase3, Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

for
Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
Location: Myrtle Beach SC, North Charleston SC, Charleston SC,
Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT06774131

Phase3, Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,
Location: Myrtle Beach SC, Raleigh NC, Durham NC,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase2, Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Myrtle Beach SC, Raleigh NC, Charleston SC,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase2, Recruiting

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

for
Castration Levels of Testosterone,
Location: Myrtle Beach SC, New Bern NC, Albemarle NC,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT03678025

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca

for
Febrile Neutropenia, Non-myeloid Malignancy
Location: Myrtle Beach SC, Charlotte NC, Rock Hill SC
Sponsor: Coherus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04662892

Recruiting

Prospective US Radiofrequency SUI Trial

for
Urinary Incontinence, Stress
Location: Myrtle Beach SC, Raleigh NC, Winston-Salem NC,
Sponsor: Viveve Inc.

Sex: Female

Age: 18+

Code: NCT04720352

Recruiting
FeaturedActive & Responsive

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

for
Hypothyroidism
Location: Wilmington NC, Myrtle Beach SC, Morehead City NC,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06345339

Phase2, Phase3, Recruiting
Featured

A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars

for
Acne Scars
Location: Wilmington NC, Arlington VA, Alpharetta GA,
Sponsor: AbbVie

Sex: All

Age: 22+

Code: NCT07207369

Phase3, Recruiting

Cosmetic Evaluation of Lumpectomy Versus Oncolytic Mammoplasty With Bilateral Breast Reduction for Early Stage Breast Cancer

for
Breast Carcinoma
Location: Wilmington NC
Sponsor: Coastal Carolina Radiation Oncology

Sex: Female

Age: 50+

Code: NCT01400399

Recruiting

Prevail Global Study

for
Coronary Artery Disease
Location: Wilmington NC, Charleston SC, Greensboro NC,
Sponsor: Medtronic Vascular

Sex: All

Age: 18+

Code: NCT06535854

Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

for
Acne
Location: Wilmington NC, Mt. Pleasant SC, Lynchburg VA,
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT06316297

Phase1, Phase2, Recruiting

Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis

for
Neurotrophic Keratitis
Location: Leland NC
Sponsor: BRIM Biotechnology Inc.

Sex: All

Age: 18+

Code: NCT05927428

Phase2, Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

for
Moderate-to-Severe Atopic Dermatitis
Location: Wilmington NC, Macon GA, New York NY, Clifton NJ,
Sponsor: Nektar Therapeutics

Sex: All

Age: 12+

Code: NCT07690371

Phase3, Recruiting